Langaware, a Greek startup, raises €2 million for AI technology that predicts and monitors cognitive and mental health conditions. The funding aims to boost its expansion in the US market.
By analysing language, voice, and speech through digital biomarkers Langaware is using AI to predict and monitor cognitive and mental health conditions including mild cognitive decline, Alzheimer’s disease, and Depression. Ultimately, this early detection aids health systems, providers, and the pharma industry in providing appropriate, bespoke patient care and support.